Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 2
2002 3
2003 5
2005 1
2006 1
2007 1
2008 1
2009 6
2010 7
2011 10
2012 14
2013 14
2014 14
2015 15
2016 12
2017 23
2018 16
2019 16
2020 13
2021 10
2022 20
2023 16
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Results by year

Filters applied: . Clear all
Page 1
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Smolen JS, Landewé RBM, Bergstra SA, Kerschbaumer A, Sepriano A, Aletaha D, Caporali R, Edwards CJ, Hyrich KL, Pope JE, de Souza S, Stamm TA, Takeuchi T, Verschueren P, Winthrop KL, Balsa A, Bathon JM, Buch MH, Burmester GR, Buttgereit F, Cardiel MH, Chatzidionysiou K, Codreanu C, Cutolo M, den Broeder AA, El Aoufy K, Finckh A, Fonseca JE, Gottenberg JE, Haavardsholm EA, Iagnocco A, Lauper K, Li Z, McInnes IB, Mysler EF, Nash P, Poor G, Ristic GG, Rivellese F, Rubbert-Roth A, Schulze-Koops H, Stoilov N, Strangfeld A, van der Helm-van Mil A, van Duuren E, Vliet Vlieland TPM, Westhovens R, van der Heijde D. Smolen JS, et al. Among authors: den broeder aa. Ann Rheum Dis. 2023 Jan;82(1):3-18. doi: 10.1136/ard-2022-223356. Epub 2022 Nov 10. Ann Rheum Dis. 2023. PMID: 36357155
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, Aletaha D, Aringer M, Askling J, Balsa A, Boers M, den Broeder AA, Buch MH, Buttgereit F, Caporali R, Cardiel MH, De Cock D, Codreanu C, Cutolo M, Edwards CJ, van Eijk-Hustings Y, Emery P, Finckh A, Gossec L, Gottenberg JE, Hetland ML, Huizinga TWJ, Koloumas M, Li Z, Mariette X, Müller-Ladner U, Mysler EF, da Silva JAP, Poór G, Pope JE, Rubbert-Roth A, Ruyssen-Witrand A, Saag KG, Strangfeld A, Takeuchi T, Voshaar M, Westhovens R, van der Heijde D. Smolen JS, et al. Among authors: den broeder aa. Ann Rheum Dis. 2020 Jun;79(6):685-699. doi: 10.1136/annrheumdis-2019-216655. Epub 2020 Jan 22. Ann Rheum Dis. 2020. PMID: 31969328 Free article.
Preface.
den Broeder AA, Woodworth TG. den Broeder AA, et al. Best Pract Res Clin Rheumatol. 2015 Aug-Dec;29(4-5):525-6. doi: 10.1016/j.berh.2015.09.008. Epub 2015 Nov 28. Best Pract Res Clin Rheumatol. 2015. PMID: 26697763 No abstract available.
Authors' reply.
Mahler E, Cuperus N, Bijlsma J, Vliet Vlieland T, van den Hoogen F, den Broeder AA, van den Ende CH. Mahler E, et al. Among authors: den broeder aa. Scand J Rheumatol. 2017 Mar;46(2):169-170. doi: 10.1080/03009742.2016.1238961. Epub 2016 Dec 13. Scand J Rheumatol. 2017. PMID: 27957869 No abstract available.
[Polymyalgia rheumatica: new developments and challenges].
Marsman DE, den Broeder AA, Boers N, van der Maas A. Marsman DE, et al. Among authors: den broeder aa. Ned Tijdschr Geneeskd. 2017;161:D1647. Ned Tijdschr Geneeskd. 2017. PMID: 29192568 Review. Dutch.
Reply.
Lesuis N, Piek E, Demirel H, den Broeder AA, Hulscher ME, Meek I, van der Laan-Baalbergen N, van Vollenhoven RF. Lesuis N, et al. Among authors: den broeder aa. Arthritis Care Res (Hoboken). 2016 Jul;68(7):1051. doi: 10.1002/acr.22809. Arthritis Care Res (Hoboken). 2016. PMID: 26662725 Free article. No abstract available.
[Medication during severe infections].
Workum JD, Huysmans FT, de Mast Q, den Broeder AA, Kramers CK. Workum JD, et al. Among authors: den broeder aa. Ned Tijdschr Geneeskd. 2020 Nov 19;164:D5039. Ned Tijdschr Geneeskd. 2020. PMID: 33332031 Dutch.
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study.
van der Togt CJT, Van den Bemt B, Aletaha D, Alten R, Chatzidionysiou K, Galloway J, Isaac J, Mulleman D, Verschueren P, Vulto AG, Welsing PMJ, Verhoef L, den Broeder AA. van der Togt CJT, et al. Among authors: den broeder aa. RMD Open. 2023 Mar;9(1):e002898. doi: 10.1136/rmdopen-2022-002898. RMD Open. 2023. PMID: 36863753 Free PMC article. Review.
196 results